Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Post-Transplant Cyclophosphamide Regimens for Unmanipulated Haploidentical Transplant in Pediatric Patients With Refractory Acute Myeloid Leukemia

NCT03654703 is registered in ClinicalTrials.gov with Capital Research Institute of Pediatrics as lead sponsor.

NCT NCT03654703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03654703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Post-Transplant Cyclophosphamide Regimens for Unmanipulated Haploidentical Transplant in Pediatric Patients With Refractory Acute Myeloid Leukemia
Lead sponsor
Capital Research Institute of Pediatrics
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2015
Completion date
March 1, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic system--cancer